Analytics works with pharmaceutical companies to first develop and then routinely monitor personal exposure and equipment clearance testing. These proprietary methods are developed by Analytics using similar OSHA/NIOSH methods and then adapting these existing methods to the unique nature of the active ingredients required for your company. The entire process is made simple by Analytics’ R&D Staff and only requires minimum input by your company to establish the Occupational Exposure Limit (OEL) and to provide a small portion of the active ingredient required for analysis. The protocol we develop can be used to analyze air exposure samples, as well as samples for wipe clearance and bulk material testing. Analytics also provides containment testing of your entire production process based on the analysis of surrogates such as lactose, naproxen, acetaminophen, and mannitol. Analytics currently has over 200 proprietary and over-the-counter active pharmaceutical ingredients (API) that we analyze routinely.